We would like to thank each of our sponsors for their generous support - as without them this event would not be possible.
- support healthcare innovation and technology that will benefit patients now and in the future
- drive faster translation of basic science discoveries into tangible benefits for patients and the economy
- help develop the people who conduct and contribute to applied health research.
PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people work tirelessly to provide quality results for clients. We offer specialized expertise across all phases, therapeutic areas and a broad spectrum of service models.
With 14,000+ employees covering 85+ countries, we deliver global presence combined with an in-depth knowledge of local regulations, standards of care and cultural customs.
At PRA, we love what do, because we are making a difference in the lives of patients and their family members worldwide. We have contributed to the development of numerous drugs now available to countless patients.
PPD is delighted to sponsor PharmaTimes International Clinical Researcher of the Year 2018. PPD is a leading global contract research organisation providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organisations. With offices in 48 countries and more than 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
Covance Inc., the drug development business of Laboratory Corporation of America Holdings (LabCorp) headquartered in Princeton, New Jersey, USA, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®.
Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, helps our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions. Information on Covance’s solutions can be obtained through its website at www.covance.com.
About the ABPI
We represent innovative biopharmaceutical companies in the UK.
Our industry, a major contributor to the economy, brings life-saving and life-enhancing medicines to patients. We represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing new medicines, ensuring that the UK remains at the forefront of helping patients prevent and overcome disease.
Globally our industry is researching and developing more than 7,000 new medicines.
The ABPI also negotiates for the branded pharmaceutical industry in statutory consultations, including the pricing scheme for medicines in the UK.
The NIHR is funded by the UK government to improve the health and wealth of the nation through research and represents the most integrated health research system in the world. We partner with all funders of research, including industry, to:
More about us: https://www.nihr.ac.uk/about-us/who-we-are/